Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

NCT00972855 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA